Full-Time

Senior Associate IS Engineer

Posted on 4/9/2025

Amgen

Amgen

10,001+ employees

Develops biologic therapies for serious illnesses

No salary listed

Mid, Senior

Hyderabad, Telangana, India

Category
Backend Engineering
IT & Support
Software Engineering
Required Skills
Microsoft Azure
Python
C#
AWS
Requirements
  • Master’s degree and 1 to 3 years of Computer Science, IT or related field experience OR
  • Bachelor’s degree and 3 to 5 years of Computer Science, IT or related field experience OR
  • Diploma and 7 to 9 years of Computer Science, IT or related field experience
  • Fluency in C#
  • Direct experience with cloud platform services including Azure or AWS (Azure preferred)
  • Strong knowledge of information systems and related technologies
  • Strong rapid prototyping skills and the ability to translate concepts into working code
Responsibilities
  • Maintain existing C# and Python code hosted in Azure and AWS
  • Independently develop, test, and deploy code based on designs generated in collaboration with the Virtual Desktop team
  • Generate code documentation
  • Deploy and maintain a robust CI/CD solution
  • Conduct code reviews to ensure code quality and adherence to best practices
Desired Qualifications
  • Working knowledge of Python
  • Familiarity with Microsoft Graph API, Azure Functions, Azure Logic Apps, and Cosmo DB
  • Familiarity with Python Boto3, AWS Lambda, DynamoDB, S3, SQS
  • Understanding of REST APIs and Database services
  • Experience with API integration, serverless, and microservices architecture
  • Strong problem solving and analytical skills
  • Be willing and able to learn new technologies at a rapid pace
  • Understanding of desktop systems lifecycle and management
  • Experience with data visualization platforms (Power BI or Tableau)

Amgen develops medicines aimed at treating serious illnesses, focusing on biotechnology. The company researches, develops, and sells biologic therapies, which are medicines made from living organisms. These therapies target conditions like cancer, cardiovascular diseases, and autoimmune disorders. Amgen stands out from competitors by reinvesting a large portion of its earnings into research and development, ensuring a strong pipeline of new treatments. The goal of Amgen is to improve patient care and address critical health challenges through its innovative therapeutic solutions.

Company Size

10,001+

Company Stage

IPO

Headquarters

Thousand Oaks, California

Founded

1980

Simplify Jobs

Simplify's Take

What believers are saying

  • Amgen's investment in AI aligns with trends in biotechnology innovation.
  • Institutional investments indicate strong market confidence in Amgen's growth.
  • FTC clearance of the Horizon merger may ease future regulatory hurdles.

What critics are saying

  • Competitors' AI-driven drug discovery could outpace Amgen's traditional R&D methods.
  • FTC scrutiny of mergers may complicate Amgen's future growth strategy.
  • Advancements in quantum technologies could pose a competitive threat to Amgen.

What makes Amgen unique

  • Amgen focuses on biologic therapies derived from living organisms.
  • The company has a strong pipeline of potential new therapies in development.
  • Amgen's acquisition of Horizon Therapeutics enhances its rare disease portfolio.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Professional Development Budget

Conference Attendance Budget

Company News

MarketBeat
Jan 28th, 2024
Factory Mutual Insurance Co. Makes New Investment in Amgen Inc. (NASDAQ:AMGN)

Factory Mutual Insurance Co. purchased a new position in Amgen Inc. (NASDAQ:AMGN - Free Report) during the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm purchased 53,500 shares of the medical research company's stock, valued at approxim

The Quantum Insider
Jan 16th, 2024
Honeywell Announces the Closing of $300 Million Equity Investment Round for Quantinuum at $5 Billion Pre-Money Valuation

JPMorgan Chase has one of the world's most highly regarded specialist teams working on quantum technologies within the financial services industry and has been working with Quantinuum and its predecessor companies since 2020.

ETF Daily News
Dec 17th, 2023
Northwest Quadrant Wealth Management LLC Invests $237,000 in Amgen Inc. (NASDAQ:AMGN)

Northwest Quadrant Wealth Management LLC bought a new position in shares of Amgen Inc. (NASDAQ:AMGN – Free Report) during the third quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund bought 883 shares of the medical research company’s stock, valued at approximately $237,000. A number of other institutional investors […]

Horizon Therapeutics
Sep 21st, 2023
Rule 2.7 Announcement: Amgen Inc to Acquire Horizon Therapeutics plc | Horizon Therapeutics plc

The Investor Relations website contains information about Horizon Therapeutics plc's business for stockholders, potential investors, and financial analysts.

BioSpace
Sep 19th, 2023
Amgen-Horizon Merger Clearance a Setback to FTC’s Antitrust Enforcement Plans

The consent agreement struck between the FTC and Amgen and Horizon Therapeutics could have significant implications for ongoing and future M&A challenges, experts told BioSpace.

INACTIVE